Advertisement
OCSL vs PCR
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is OCSL is a Buy and PCR is a Buy.
OCSL's MACD Histogram crosses above signal line
The Moving Average Convergence Divergence (MACD) for OCSL turned positive on October 26, 2026. Looking at past instances where OCSL's MACD turned positive, the stock continued to rise in 19 of 41 cases over the following month. The odds of a continued upward trend are 46%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where OCSL's RSI Oscillator exited the oversold zone, 11 of 26 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 42%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 26 of 62 cases where OCSL's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 42%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on OCSL as a result. In 33 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 38%.
Following a +1.92% 3-day Advance, the price is estimated to grow further. Considering data from situations where OCSL advanced for three days, in 115 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 37%.
Bearish Trend Analysis
OCSL moved below its 50-day moving average on September 23, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for OCSL crossed bearishly below the 50-day moving average on September 29, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 16 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 50%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where OCSL declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 48%.
The Aroon Indicator for OCSL entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
Fundamental Analysis (Ratings)
The Tickeron SMR rating for this company is 39 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron PE Growth Rating for this company is 45 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Seasonality Score of 65 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.
The Tickeron Price Growth Rating for this company is 69 (best 1 - 100 worst), indicating slightly worse than average price growth. OCSL’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 94 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.752) is normal, around the industry mean (2.390). P/E Ratio (24.583) is within average values for comparable stocks, (-3.879). Projected Growth (PEG Ratio) (0.934) is also within normal values, averaging (1.319). Dividend Yield (0.112) settles around the average of (0.271) among similar stocks. P/S Ratio (20.450) is also within normal values, averaging (15.798).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. OCSL’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 82, placing this stock worse than average.
PCR in upward trend: price expected to rise as it breaks its lower Bollinger Band on October 14, 2026
PCR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In 8 of 11 cases where PCR's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are 73%.
Technical Analysis (Indicators)
Bullish Trend Analysis
The RSI Indicator points to a transition from a downward trend to an upward trend -- in cases where PCR's RSI Indicator exited the oversold zone, 10 of 14 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 71%.
The Momentum Indicator moved above the 0 level on October 23, 2026. You may want to consider a long position or call options on PCR as a result. In 13 of 18 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 72%.
The Moving Average Convergence Divergence (MACD) for PCR just turned positive on October 16, 2026. Looking at past instances where PCR's MACD turned positive, the stock continued to rise in 5 of 7 cases over the following month. The odds of a continued upward trend are 71%.
Bearish Trend Analysis
The Stochastic Oscillator demonstrated that the ticker has stayed in the overbought zone for 4 days. The longer the ticker stays in the overbought zone, the sooner a price pull-back is expected.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PCR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 87%.
The Aroon Indicator for PCR entered a downward trend on October 27, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
OCSL | ||
|---|---|---|
OUTLOOK RATING 1..100 | 61 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 94 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 39 | |
PRICE GROWTH RATING 1..100 | 69 | |
P/E GROWTH RATING 1..100 | 45 | |
SEASONALITY SCORE 1..100 | 65 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| OCSL | PCR | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 42% | 2 days ago 71% |
| Stochastic ODDS (%) | 2 days ago 42% | 2 days ago 90% |
| Momentum ODDS (%) | 2 days ago 38% | 2 days ago 72% |
| MACD ODDS (%) | 2 days ago 46% | 2 days ago 71% |
| TrendWeek ODDS (%) | 2 days ago 35% | 2 days ago 66% |
| TrendMonth ODDS (%) | 2 days ago 40% | 2 days ago 85% |
| Advances ODDS (%) | 2 days ago 37% | N/A |
| Declines ODDS (%) | 8 days ago 48% | 15 days ago 87% |
| BollingerBands ODDS (%) | N/A | 2 days ago 73% |
| Aroon ODDS (%) | 2 days ago 42% | 2 days ago 85% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
OCSL’s FA Score shows that 0 FA rating(s) are green while .
- OCSL’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
OCSL’s TA Score shows that 5 TA indicator(s) are bullish.
- OCSL’s TA Score: 5 bullish, 4 bearish.
Price Growth
OCSL (@Investment Managers) experienced а +4.89% price change this weekfor the same time period.
The average weekly price growth across all stocks in the @Investment Managers industry was +0.13%. For the same industry, the average monthly price growth was -5.77%, and the average quarterly price growth was -2.63%.
Reported Earning Dates
OCSL is expected to report earnings on Nov 17, 2026.
Industries' Descriptions
@Investment Managers (+0.13% weekly)Investment Managers manage financial assets and other investments of clients. Management includes designing a short- or long-term strategy for buying/holding and selling of portfolio holdings. It can also include tax services and other aspects of financial planning as well. While it is perceived that the industry is faced with growing competition from robo-advisors/digital platforms and passive/ index-tracking funds, many investors still find value in actively managed in-person services that investment management companies often emphasize on. At the same time, many wealth managers are also incorporating digital initiatives/low cost options in addition to their in-person customized services. Their main sources of revenues are fees as a percentage of assets under management, in addition to a certain portion of clients’ gains from asset appreciation. BlackRock, Inc., Blackstone Group Inc and Brookfield Asset Management are some of the major investment management companies.
Advertisement
OCSL and
Correlation & Price change
A.I.dvisor indicates that over the last year, OCSL has been closely correlated with PFLT. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if OCSL jumps, then PFLT could also see price increases.
| Ticker / NAME | Correlation To OCSL | 1D Price Change % | ||
|---|---|---|---|---|
| OCSL | 100% | +1.30% | ||
| PFLT - OCSL | 71% Closely correlated | +2.95% | ||
| ARCC - OCSL | 71% Closely correlated | -0.54% | ||
| BCSF - OCSL | 70% Closely correlated | +3.98% | ||
| GBDC - OCSL | 70% Closely correlated | +1.98% | ||
| MSDL - OCSL | 69% Closely correlated | +2.33% | ||
More | ||||
PCR and
Correlation & Price change
A.I.dvisor indicates that over the last year, PCR has been loosely correlated with MSDL. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if PCR jumps, then MSDL could also see price increases.
| Ticker / NAME | Correlation To PCR | 1D Price Change % | ||
|---|---|---|---|---|
| PCR | 100% | -0.06% | ||
| MSDL - PCR | 63% Loosely correlated | +2.33% | ||
| GBDC - PCR | 62% Loosely correlated | +1.98% | ||
| ARCC - PCR | 61% Loosely correlated | -0.54% | ||
| OCSL - PCR | 60% Loosely correlated | +1.30% | ||
| BBDC - PCR | 60% Loosely correlated | +2.41% | ||
More | ||||